![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 12
Zeitschriftenartikel
Al-Sawaf, O.; Robrecht, S.; Bahlo, J.; Fink, A. M.; Cramer, P.; Tresckow, J. von; Lange, E.; Kiehl, M.; Dreyling, M.; Ritgen, M.; Duerig, J.; Tausch, E.; Schneider, C.; Stilgenbauer, S.; Wendtner, C. M.; Fischer, K.; Goede, V.; Hallek, M. und Eichhorst, B.
(2020):
Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials.
In: Leukemia, Bd. 35, Nr. 1: S. 169-176
Andersson, Nadine G.; Chalmers, Elizabeth A.; Kenet, Gili; Ljung, Rolf; Makipernaa, Anne; Chambost, Herve; Altisent Roca, C.; Alvarez Roman, M. T.; Buehrlen, M.; van den Berg, H. M.; Chalmers, E.; Chambost, H.; Rosa Cid, A.; Claeyssens, S.; Escuriola, C.; Fischer, K.; Van Geet, C.; Kobelt, R.; Königs, C.; Kurnik, K.; Liesner, R.; Ljung, R.; Makipernaa, A.; Molinari, A.; Muntean, W.; Nolan, B.; Oldenburg, J.; Perez Garrido, R.; Platokouki, H.; Rafowicz, A.; Ranta, S.; Santagostino, E.; Mancuso, M. E.; Bonomi, Angelo Bianchi; Mikkelsen, T. Stamm; Thomas, A.; Kenet, G.; Williams, M.; Carcao, M. und Rivard, G.
(2019):
Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds.
In: Haematologica, Bd. 104, Nr. 10: S. 2100-2106
Platokouki, H.; Fischer, K.; Gouw, S. C.; Rafowicz, A.; Carcao, M.; Kenet, G.; Liesner, R.; Kurnik, K.; Rivard, G. E. und Berg, H. M. van den
(2018):
Vaccinations are not associated with inhibitor development in boys with severe haemophilia A.
In: Haemophilia, Bd. 24, Nr. 2: S. 283-290
Cramer, P.; Tresckow, J. von; Bahlo, J.; Robrecht, S.; Al Sawaf, O.; Langerbeins, P.; Engelke, A.; Fink, A.-M.; Fischer, K.; Seiler, T.; Fischer von Weikersthal, L.; Hebart, H.; Kreuzer, K.-A.; Ritgen, M.; Kneba, M.; Wendtner, C.-M.; Stilgenbauer, S.; Eichhorst, B. und Hallek, M.
(2017):
BENDAMUSTINE (B), followed by OBINUTUZUMAB (G, GA101) and VENETOCLAX (A, ABT-199) in patients with chronic lymphocytic leukemia (CLL): CLL2-BAG PHASE-II-TRIAL of the German CLL Study Group (GCLLSG).
In: Hämatologica, Bd. 102: S. 171-172
Fischer, K.; Poonnoose, P.; Dunn, A. L.; Babyn, P.; Manco-Johnson, M. J.; David, J. A.; Net, J. van der; Feldman, B.; Berger, K.; Carcao, M.; Kleijn, P. de; Silva, M.; Hilliard, P.; Doria, A.; Srivastava, A. und Blanchette, V.
(2017):
Choosing outcome assessment tools in hämophilia care and research: a multidisciplinary perspective.
In: Hämophilia, Bd. 23, Nr. 1: S. 11-24
[PDF, 135kB]
Al-Sawaf, O.; Robrecht, S.; Bahlo, J.; Fink, A. M.; Cramer, P.; Tresckow, J. von; Maurer, C.; Bergmann, M.; Seiler, T.; Lange, E.; Kneba, M.; Stilgenbauer, S.; Döhner, H.; Kiehl, M. G.; Jäger, U.; Wendtner, C. M.; Fischer, K.; Göde, V.; Hallek, M.; Eichhorst, B. und Hopfinger, G.
(2017):
Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group.
In: Leukemia, Bd. 31, Nr. 10: S. 2251-2253
Fischer, K.; Königs, C.; Liphardt, K.; Oliveira, C. und Kurnik, K.
(2017):
Bleeding FVIII Inhibitor Patients - Data From the Remain Study of the Pednet Study Group.
In: Haemophilia, Bd. 23: S. 18
Cramer, P.; Tresckow, J. von; Bahlo, J.; Robrecht, S.; Al-Sawaf, O.; Langerbeins, P.; Engelke, A.; Fink, A.-M.; Fischer, K.; Tausch, E.; Seiler, T.; Fischer von Weikersthal, L.; Hebart, H.; Kreuzer, K.-A.; Ritgen, M.; Kneba, M.; Wendtner, C.-M.; Stilgenbauer, S.; Eichhorst, B. und Hallek, M.
(2017):
Bendamustine (B), followed by obinutuzumab (G) and venetoclax (A) in patients with chronic lymphocytic leukemia (CLL): CLL2-BAG trial of the German CLL Study Group (GCLLSG).
In: Oncology Research and Treatment, Bd. 40: S. 24
Abicht, J.; Mayr, T. A.; Fischer, K.; Reichart, B.; Niemann, H.; Panelli, A.; Guethoff, S.; Brenner, P. und Schnieke, A.
(2016):
Ex Vivo Testing of New Genetical Modifications for Cardiac Xenotransplantation.
In: Journal of Heart and Lung Transplantation, Bd. 35, Nr. 4:
S186-S187
Nijdam, A.; Bladen, M.; Hubert, N.; Pettersson, M.; Bartels, B.; Net, J. van der; Liesner, R.; Petrini, P.; Kurnik, K. und Fischer, K.
(2016):
Using routine Haemophilia Joint Health Score for international comparisons of haemophilia outcome: standardization is needed.
In: Haemophilia, Bd. 22, Nr. 1: S. 142-147
Maurer, C.; Langerbeins, P.; Bahlo, J.; Cramer, P.; Fink, A. M.; Pflug, N.; Engelke, A.; Tresckow, J. von; Kovacs, G.; Stilgenbauer, S.; Wendtner, C.-M.; Müller, L.; Ritgen, M.; Seiler, T.; Fischer, K.; Hallek, M. und Eichhorst, B.
(2016):
Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL.
In: Leukemia, Bd. 30, Nr. 10: S. 2019-2025
Al-Sawaf, O.; Kluth, S.; Bahlo, J.; Hopfinger, G.; Fink, A. M.; Cramer, P.; Maurer, C.; Bergmann, M.; Dreyling, M.; Lange, E.; Kneba, M.; Stilgenbauer, S.; Kiehl, M. G.; Jäger, U.; Wendtner, C. M.; Fischer, K.; Hallek, M. und Eichhorst, B.
(2016):
Impact of gender on outcome after chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab (FCR) or bendamustin plus R (BR) in CLL patients: a pooled analysis of the German CLL Study Group (GCLLSG).
In: Oncology Research and Treatment, Bd. 39: S. 212-213